BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30833548)

  • 1. Inhibition of lymphatic proliferation by the selective VEGFR-3 inhibitor SAR131675 ameliorates diabetic nephropathy in db/db mice.
    Hwang SD; Song JH; Kim Y; Lim JH; Kim MY; Kim EN; Hong YA; Chung S; Choi BS; Kim YS; Park CW
    Cell Death Dis; 2019 Mar; 10(3):219. PubMed ID: 30833548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated Lymphatic Proliferation Ameliorates Diabetic Nephropathy and High-Fat Diet-Induced Renal Lipotoxicity.
    Kim Y; Hwang SD; Lim JH; Kim MY; Kim EN; Choi BS; Kim YS; Kim HW; Park CW
    Sci Rep; 2019 Feb; 9(1):1994. PubMed ID: 30760777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAR131675, a potent and selective VEGFR-3-TK inhibitor with antilymphangiogenic, antitumoral, and antimetastatic activities.
    Alam A; Blanc I; Gueguen-Dorbes G; Duclos O; Bonnin J; Barron P; Laplace MC; Morin G; Gaujarengues F; Dol F; Hérault JP; Schaeffer P; Savi P; Bono F
    Mol Cancer Ther; 2012 Aug; 11(8):1637-49. PubMed ID: 22584122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic inflammation, lymphangiogenesis, and effect of an anti-VEGFR therapy in a mouse model and in human patients with aspiration pneumonia.
    Nihei M; Okazaki T; Ebihara S; Kobayashi M; Niu K; Gui P; Tamai T; Nukiwa T; Yamaya M; Kikuchi T; Nagatomi R; Ebihara T; Ichinose M
    J Pathol; 2015 Mar; 235(4):632-45. PubMed ID: 25348279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy.
    Choi SR; Lim JH; Kim MY; Kim EN; Kim Y; Choi BS; Kim YS; Kim HW; Lim KM; Kim MJ; Park CW
    Metabolism; 2018 Aug; 85():348-360. PubMed ID: 29462574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.
    Kim Y; Lim JH; Kim MY; Kim EN; Yoon HE; Shin SJ; Choi BS; Kim YS; Chang YS; Park CW
    J Am Soc Nephrol; 2018 Apr; 29(4):1108-1127. PubMed ID: 29330340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury.
    Chow F; Ozols E; Nikolic-Paterson DJ; Atkins RC; Tesch GH
    Kidney Int; 2004 Jan; 65(1):116-28. PubMed ID: 14675042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Superoxide Dismutase Attenuates Renal Oxidative Stress Through the Activation of Adenosine Monophosphate-Activated Protein Kinase in Diabetic Nephropathy.
    Hong YA; Lim JH; Kim MY; Kim Y; Park HS; Kim HW; Choi BS; Chang YS; Kim HW; Kim TY; Park CW
    Antioxid Redox Signal; 2018 Jun; 28(17):1543-1561. PubMed ID: 29020797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-Shogaol ameliorates diabetic nephropathy through anti-inflammatory, hyperlipidemic, anti-oxidative activity in db/db mice.
    Xu Y; Bai L; Chen X; Li Y; Qin Y; Meng X; Zhang Q
    Biomed Pharmacother; 2018 Jan; 97():633-641. PubMed ID: 29101807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthocyanin-rich Seoritae extract ameliorates renal lipotoxicity via activation of AMP-activated protein kinase in diabetic mice.
    Koh ES; Lim JH; Kim MY; Chung S; Shin SJ; Choi BS; Kim HW; Hwang SY; Kim SW; Park CW; Chang YS
    J Transl Med; 2015 Jun; 13():203. PubMed ID: 26116070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice.
    Seok SJ; Lee ES; Kim GT; Hyun M; Lee JH; Chen S; Choi R; Kim HM; Lee EY; Chung CH
    Nephrol Dial Transplant; 2013 Jul; 28(7):1700-10. PubMed ID: 23794669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarpogrelate hydrochloride ameliorates diabetic nephropathy associated with inhibition of macrophage activity and inflammatory reaction in db/db mice.
    Lee ES; Lee MY; Kwon MH; Kim HM; Kang JS; Kim YM; Lee EY; Chung CH
    PLoS One; 2017; 12(6):e0179221. PubMed ID: 28640832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury.
    Aroor AR; Das NA; Carpenter AJ; Habibi J; Jia G; Ramirez-Perez FI; Martinez-Lemus L; Manrique-Acevedo CM; Hayden MR; Duta C; Nistala R; Mayoux E; Padilla J; Chandrasekar B; DeMarco VG
    Cardiovasc Diabetol; 2018 Jul; 17(1):108. PubMed ID: 30060748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing.
    Maruyama K; Asai J; Ii M; Thorne T; Losordo DW; D'Amore PA
    Am J Pathol; 2007 Apr; 170(4):1178-91. PubMed ID: 17392158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyanidin-3-O-glucoside ameliorates diabetic nephropathy through regulation of glutathione pool.
    Qin Y; Zhai Q; Li Y; Cao M; Xu Y; Zhao K; Wang T
    Biomed Pharmacother; 2018 Jul; 103():1223-1230. PubMed ID: 29864902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
    Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
    Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody.
    Flyvbjerg A; Dagnaes-Hansen F; De Vriese AS; Schrijvers BF; Tilton RG; Rasch R
    Diabetes; 2002 Oct; 51(10):3090-4. PubMed ID: 12351452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes.
    Sedeek M; Gutsol A; Montezano AC; Burger D; Nguyen Dinh Cat A; Kennedy CR; Burns KD; Cooper ME; Jandeleit-Dahm K; Page P; Szyndralewiez C; Heitz F; Hebert RL; Touyz RM
    Clin Sci (Lond); 2013 Feb; 124(3):191-202. PubMed ID: 22920224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy.
    Park HS; Lim JH; Kim MY; Kim Y; Hong YA; Choi SR; Chung S; Kim HW; Choi BS; Kim YS; Chang YS; Park CW
    J Transl Med; 2016 Jun; 14(1):176. PubMed ID: 27286657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An aqueous extract of Portulaca oleracea ameliorates diabetic nephropathy through suppression of renal fibrosis and inflammation in diabetic db/db mice.
    Lee AS; Lee YJ; Lee SM; Yoon JJ; Kim JS; Kang DG; Lee HS
    Am J Chin Med; 2012; 40(3):495-510. PubMed ID: 22745066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.